A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Yoneda A, Shichino H, Hishiki T, Matsumoto K, Ohira M, Kamijo T, Kuroda T, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Hara J, Kaneko M, Ikeda H, Tajiri T, Mugishima H, Nakagawara A.
Yoneda A, et al.
Pediatr Blood Cancer. 2024 Jun;71(6):e30976. doi: 10.1002/pbc.30976. Epub 2024 Apr 5.
Pediatr Blood Cancer. 2024.
PMID: 38577760
Clinical Trial.